On March 3, 2010
What New Bristol-Myers CEO Can Expect: More Management Churn and Animal Rights Protests
The ascent of Lamberto Andreotti to CEO of Bristol-Myers Squibb (BMY) sets the stage for two events: Potential continued churn in BMS leadership and a renewed series of attacks from animal rights activists, for whom Andreotti is already a bete
…
0 Comments